My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED

Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cybin Inc. Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More ↗

August 03, 2023

A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...

Via Benzinga

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

Analyst Expectations for Cybin's Future ↗

July 03, 2023

Via Benzinga

Cybin: Q4 Earnings Insights ↗

June 27, 2023

Via Benzinga

Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal ↗

August 01, 2023

Psychedelics company Cybin Inc. (NYSE: CYBN) announced an overnight marketed public offering of its units and confirmed its set pricing on an aggregate 24,264,706 Cybin units, at $0.34 each, for...

Via Benzinga

US Stocks Mixed; Pfizer Earnings Beat Views ↗

August 01, 2023

U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to...

Via Benzinga

Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

August 01, 2023

Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 01, 2023

It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning!

Via InvestorPlace

Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials ↗

July 24, 2023

Cybin One Steps Away From Complete Dosing

Via Benzinga

A Quantum Leap In Psychedelic Research: Study Shows Real-Time Brain Changes After Ketamine Use ↗

July 21, 2023

A newly published study shows that Kernel’s Flow technology system is in fact able to capture and analyze brain changes following the administration of a psychoactive substance.

Via Benzinga

Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session ↗

July 06, 2023

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.

Via Benzinga

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More ↗

July 04, 2023

World's Largest Psychedelics Conference Boasts 12K Attendees

Via Benzinga

Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor ↗

June 28, 2023

Psychedelics biopharma company Cybin Inc. (NYSE: CYBN) shared its financial results for the fiscal year ended this March 31 as well as recent business highlights. Numbers show: Total cash of $12.5...

Via Benzinga

Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More ↗

June 06, 2023

Major Investor Commits $30 Million To Psychedelics Funding

Via Benzinga

May Summary Of Largest Psychedelic Compound-Based Drug Stock Performances ↗

June 01, 2023

Only two of the seven largest psychedelic compound-based drug stocks tracked, advanced in May.

Via Talk Markets

Major Investor Commits $30M To Psychedelics Funding ↗

May 31, 2023

Canadian psychedelics biotech Cybin Inc. (NYSE: CYBN) entered into a common share purchase agreement with institutional investor Lincoln Park Capital Fund (LPC) for the sale of up to $30...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More ↗

May 31, 2023

Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...

Via Benzinga

Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes ↗

May 24, 2023

Canadian clinical-stage psychedelics company Cybin Inc. (NYSE: CYBN) announced that the first group of participants have been dosed with its proprietary deuterated DMT molecule, CYB004, in an ongoing

Via Benzinga

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗

May 15, 2023

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths...

Via Benzinga

Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released ↗

May 09, 2023

Clinical-stage biopharma company Cybin Inc. (NYSE: CYBN) has completed participant dosing on the part 2 of 3 of its Phase 1 trial assessing intravenous (IV) administration of proprietary DMT drug...

Via Benzinga

April Psychedelic Drug Stocks Recap: The Ups And Downs ↗

April 30, 2023

Via Talk Markets

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 21, 2023

Via Benzinga

Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

April 20, 2023

Via Benzinga

Cybin, Mind Medicine Among Top Psychedelic Movers Of Today ↗

April 19, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 18, 2023 ↗

April 18, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 17, 2023 ↗

April 17, 2023

Via Benzinga

Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More ↗

April 17, 2023

Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules

Via Benzinga

ATAI Life Sciences, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

April 14, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From April 13, 2023 ↗

April 13, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.